VCYT
Veracyte Inc
Price:  
20.80 
USD
Volume:  
460,682.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Veracyte Relative Valuation

-221.9%
Upside

As of 2024-05-27, the Relative Valuation of Veracyte Inc (VCYT) is (25.35) USD. This relative valuation is based on P/E multiples. With the latest stock price at 20.80 USD, the upside of Veracyte Inc based on Relative Valuation is -221.9%.

The range of the Relative Valuation is (25.06) - (25.42) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 28.1x - 29.3x 28.7x
Forward P/E multiples 27.8x - 28.5x 28.2x
Fair Price (25.06) - (25.42) (25.35)
Upside -220.5% - -222.2% -221.9%
20.80 USD
Stock Price
(25.35) USD
Fair Price

Veracyte Relative Valuation - Historical P/E Data

Date P/E
2024-05-24 -23.32
2024-05-23 -23.37
2024-05-22 -24.24
2024-05-21 -24.42
2024-05-20 -25.01
2024-05-17 -25.66
2024-05-16 -26.24
2024-05-15 -26.41
2024-05-14 -25.81
2024-05-13 -25.23
2024-05-10 -23.96
2024-05-09 -23.13
2024-05-08 -22.56
2024-05-07 -23.58
2024-05-06 -23.46
2024-05-03 -22.82
2024-05-02 -22.64
2024-05-01 -22.57
2024-04-30 -21.94
2024-04-29 -22.81
2024-04-26 -21.65
2024-04-25 -21.84
2024-04-24 -22.31
2024-04-23 -22.24
2024-04-22 -22.26
2024-04-19 -21.81
2024-04-18 -21.53
2024-04-17 -21.15
2024-04-16 -21.22
2024-04-15 -21.72
2024-04-12 -22.68
2024-04-11 -23.25
2024-04-10 -23.22
2024-04-09 -24.03
2024-04-08 -23.20
2024-04-05 -22.56
2024-04-04 -22.62
2024-04-03 -23.13
2024-04-02 -23.00
2024-04-01 -24.27
2024-03-28 -24.85
2024-03-27 -24.36
2024-03-26 -23.73
2024-03-25 -23.55
2024-03-22 -23.65
2024-03-21 -24.19
2024-03-20 -24.23
2024-03-19 -24.30
2024-03-18 -24.20
2024-03-15 -23.66